Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis

Medical Science Monitor

Volumn 14, Issue 12, 2008, Pages

  Szperl, Malgorzata ^a   Dzielinska, Zofia ^a   Roszczynko, Marta ^a   Malek, Lukasz A ^a   Makowiecka Ciesla, Magdalena ^a   Demkow, Marcin ^a   Kadziela, Jacek ^a   Prejbisz, Aleksander ^a   Florczak, Elzbieta ^a   Zielinski, Tomasz ^a   Januszewicz, Andrzej ^a   Ruzyllo, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Coronary artery disease; Hypertension; Methylenetetrahydrofolate reductase; Nitric oxide synthase; Polymorphism; Renal artery stenosis; Renin angiotensin system

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

BASE SEQUENCE; CORONARY ARTERY DISEASE; DNA PRIMERS; FEMALE; GENETIC VARIATION; HUMANS; HYPERTENSION; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIVARIATE ANALYSIS; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION;

EID: 57349169364     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. McLaughlin K, Jardine AG, Moss JG: ABC of arterial and venous disease. Renal artery stenosis. BMJ, 2000; 320: 1124-27
2. Missouris CG, Barley J, Jeffery S et al: Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int, 1996; 49: 534-37
3. Olivieri O, Trabetti E, Grazioli S et al: Genetic polymorphisms of the renin-angiotensin system and atheromatous renal artery stenosis. Hypertension, 1999; 34: 1097-100
4. Losito A, Parente B, Cao PG et al: ACE gene polymorphism and survival in the atherosclerotic renovascular disease. Am J Kidney Dis, 2000; 35: 211-15
5. Olivieri O, Grazioli S, Pizzolo F et al: Different impact of deletion polymorphism of gene on the risk of renal and coronary artery disease. J Hypertens, 2002; 20: 37-43
6. Pizzolo F, Mansueto G, Minniti S et al: Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg, 2004; 39: 140-47
7. Reis KA, Onal B, Gonen S et al: Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to renovascular disease. Cardiovasc Intervent Radiol, 2006; 29: 59-63
8. van Onna M, Kroon AA, Houben AJ et al: Genetic risk of atherosclerotic renal artery disease. The candidate gene approach in a renal angiography cohort. Hypertension, 2004; 44: 448-53
9. Kardia SL, Bielak LF, Lange LA et al: Epistatic effects between two genes in the renin-angiotensin system and systolic blood pressure and coronary artery calcification. Med Sci Monit, 2006; 12(4): CR150-58
10. Olivieri O, Friso S, Trabetti E et al: Homocysteine and atheromatous renal artery stenosis. Clin Exp Med, 2001; 1: 211-18
11. Lusis AJ, Fogelman AM, Fonarow GC: Genetic basis of atherosclerosis: part II: clinical implications. Circulation, 2004; 110: 2066-71
12. Arnett DK, Baird AE, Barkley RA et al: American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation, 2007; 115: 2878-901
13. Dzielinska Z, Januszewicz A, Demkow M et al: Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery disease. J Hypertens, 2007; 25: 663-70
14. Sambrook J, Fritsch EF, Maniatis T (eds.): Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989
15. Frosst P, Blom HJ, Milos R et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995; 10: 111-13
16. Rice TK, Schork NJ, Rao DC: Methods for handling multiple testing. Adv Genet, 2008; 60: 293-308
17. Sayed-Tabatabaei FA, Oostra BA, Isaacs A et al: ACE polymorphisms. Cir Res, 2006; 98: 1123-33
18. Dupont WD, Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials, 1990; 11: 116-28
19. Barley J, Blackwood A, Carter ND et al: Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens, 1994; 12: 955-57
20. Barley J, Blackwood A, Miller M et al: Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-agniotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens, 1996; 10: 31-35
21. Nielsen DM, Ehm MG, Weir BS: Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet, 1999; 63: 1531-40
22. Kauma H, Päivänsalo M, Savolainen MJ et al: Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens, 1996; 14: 1183-87
23. Pfohl M, Fetter M, Koch M et al: Association between angiotensin I-converting enzyme genotypes, extracranial artery stenosis, and stroke. Atherosclerosis, 1998; 140: 161-66
24. Losito A, Selvi A, Jeffery S et al: Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension. Am J Hypertens, 2000; 13: 128-33
25. Balkestein EJ, Wang JG, Struijeker-Boudier HA et al: Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens, 2002; 20: 1551-61
26. Balkestein EJ, Staessen JA, Wang JG et al: Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension, 2001; 38: 1190-97
27. Katsuya T, Horiuchi M, Chen YD et al: Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol, 1995; 15: 779-82
28. Yang Z, Ming XF: Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res, 2006; 4: 53-65
29. Rossi GP, Maiolino G, Zanchetta M et al: The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients. J Am Coll Cardiol, 2006; 48: 1166-74
30. Hingorani AD, Liang CF, Fatibene J et al: A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation, 1999; 100: 1515-20
31. Rossi GP, Cesari M, Zanchetta M et al: The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol, 2003; 41: 930-37
32. Colombo MG, Paradossi U, Andreassi MG et al: Endothelial nitric oxide synthase gene polymorphisms and the risk of coronary artery disease. Clin Chem, 2003; 49: 389-95
33. Karvonen J, Kauma H, Kervinen K et al: Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricle mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med, 2002; 251: 102-10
34. van Bockxmeer FM, Mamotte CD, Vasikaran SD , Taylor RR: Methylenet etrahydrofolate reductase gene and coronary artery disease. Circulation, 1997; 95: 21-23
35. Verhoef P, Rimm EB, Hunter DJ et al: A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men. J Am Coll Cardiol, 1998; 32: 353-59